Further validation of synergistic effects of MG132 and rapamycin with ibrutinib in HL-60 cells and CLL cell lines MEC1 and A20 was performed using apoptosis Annexin IV assay (Figure 1C, Figures S3 and S4). This evidence concerns the gene ANXA4 and B-cell chronic lymphocytic leukemia.